Role of NIAM, A Putative Cancer Gene, in Chromosomal Instability and Glioblastoma

NIAM（一种假定的癌症基因）在染色体不稳定和胶质母细胞瘤中的作用

• 批准号: 8549696
• 负责人: Sara Marie Francis-Reed
• 金额: $ 2.82万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8549696
• 关键词: Acetylation; Address; Adult; Affect; Binding; Biochemistry; Biological; Biological Assay; Biological Markers; Biological Process; Biology; Brain Neoplasms; Cancer Biology; Cell Proliferation; Cells; Cellular biology; Chromatin; Chromosomal Instability; Chromosomal Stability; DNA Damage; DNA Repair; DNA damage checkpoint; Data; Detection; Development; Diagnosis; Disease; Down-Regulation; Educational process of instructing; Faculty; Fibroblasts; Future; Gene Expression; Gene Proteins; Genetic Transcription; Genome; Genomics; Glioblastoma; Gliomagenesis; Goals; Human; Knowledge; Laboratories; Learning; Link; Malignant Childhood Neoplasm; Malignant Neoplasms; Malignant neoplasm of brain; Measures; Mediating; Mentors; Messenger RNA; Methods; Molecular; Molecular Biology; Nuclear; Oncogenes; Outcome; Pathway interactions; Patients; Physicians; Prognostic Marker; Property; Protein p53; Proteins; Regimen; Regulation; Role; Sampling; Scientist; Signal Transduction; Techniques; Testing; Therapeutic; Time; Training; Tumor Suppressor Proteins; Work; anticancer research; base; cancer genomics; career; design; effective therapy; experience; histone acetyltransferase; improved; mRNA Expression; member; mortality; mutant; novel; overexpression; prevent; research study; response; skills; transcription factor; tumor; tumorigenesis; tumorigenic; undergraduate student

DESCRIPTION (provided by applicant): Uncontrolled cellular proliferation, altered p53 tumor suppressor signaling, and chromosomal instability (CIN) are signature features of tumorigenesis. My thesis laboratory discovered a new activator of p53 signaling called NIAM (Nuclear Interactor of ARF and Mdm2). NIAM is a novel protein that prevents CIN and inhibits cell proliferation, and its mRNA is reduced in human cancers such as glioblastoma multiforme (GBM). NIAM has functional connections with ARF, Mdm2 and p53 yet it can suppress proliferation and CIN independent of all three factors. Thus, NIAM functions in multiple anti-cancer pathways. How NIAM maintains chromosome stability and its significance in cancer are unknown. A major cause of CIN is faulty DNA damage repair. Our preliminary data reveal NIAM is a chromatin-associated protein that localizes to DNA repair foci, enhances the DNA damage response, and binds the histone acetyltransferase Tip60. Like NIAM, Tip60 binds chromatin, activates p53 and interacts functionally with ARF and Mdm2. Tip60 can also act independently of ARF-Mdm2- p53 to activate DNA damage checkpoints, promote DNA repair, and maintain chromosome stability. Based on these observations, I hypothesize that NIAM is a tumor suppressor that inhibits CIN and cancer through its interaction with Tip60 and/or promoting DNA repair. Three aims are proposed to test that hypothesis and define the biological function of NIAM using complementary molecular, biological and genomic approaches. Aim 1: Determine if NIAM maintains chromosomal stability through chromatin association and DNA damage repair. Aim 2: Define the molecular basis and significance of NIAM-Tip60 association. Aim 3: Determine if there is a link between NIAM loss, CIN and cancer. These studies are novel and significant because they will define the mechanisms by which NIAM, a putative tumor suppressor, maintains chromosomal stability and thus genomic integrity. Experiments (Aim 3) also explore the significance of altered NIAM expression and CIN in GBM, the most aggressive and prevalent type of adult brain cancer. This work may improve the diagnosis and treatment of GBM, a deadly cancer which still lack effective therapies. Importantly, this is a multi-disciplinar thesis project that will greatly advance my skills in molecular cell biology and teach me how to study the mechanisms, biology and genomics of cancer. My ultimate goal is to become an independent physician scientist studying pediatric cancers. I am excited that this training experience will effectively prepare me for such a career in translational cancer research.

描述（由申请方提供）：不受控制的细胞增殖、改变的p53肿瘤抑制信号和染色体不稳定性（CIN）是肿瘤发生的特征。我的论文实验室发现了一种新的p53信号激活剂，称为NIAM（ARF和Mdm 2的核相互作用物）。NIAM是一种新型蛋白质，可预防CIN并抑制细胞增殖，其mRNA在人类癌症如多形性胶质母细胞瘤（GBM）中减少。NIAM与ARF、Mdm 2和p53有功能性联系，但它可以独立于所有三个因素抑制增殖和CIN。因此，NIAM在多种抗癌途径中发挥作用。NIAM如何维持染色体稳定性及其在癌症中的意义尚不清楚。CIN的一个主要原因是DNA损伤修复缺陷。我们的初步数据显示，NIAM是一种染色质相关蛋白，定位于DNA修复灶，增强DNA损伤反应，并结合组蛋白乙酰转移酶Tip 60。像NIAM一样，Tip 60结合染色质，激活p53，并与ARF和Mdm 2功能性相互作用。Tip 60也可以独立于ARF-Mdm 2- p53发挥作用，激活DNA损伤检查点，促进DNA修复，并维持染色体稳定性。基于这些观察，我假设NIAM是一种肿瘤抑制因子，通过与Tip 60相互作用和/或促进DNA修复来抑制CIN和癌症。提出了三个目标，以测试这一假设，并使用互补的分子，生物学和基因组方法定义NIAM的生物学功能。目的1：确定NIAM是否通过染色质缔合和DNA损伤修复来维持染色体稳定性。目的2：明确NIAM-Tip 60结合的分子基础及意义。目的3：确定NIAM丢失、CIN和癌症之间是否存在联系。这些研究是新颖和重要的，因为它们将定义NIAM（一种假定的肿瘤抑制因子）维持染色体稳定性从而维持基因组完整性的机制。实验（目的3）还探索了改变的NIAM表达和CIN在GBM中的意义，GBM是最具侵袭性和最普遍的成人脑癌类型。这项工作可能会改善GBM的诊断和治疗，GBM是一种致命的癌症，目前仍缺乏有效的治疗方法。重要的是，这是一个多学科的论文项目，将大大提高我在分子细胞生物学的技能，教我如何研究癌症的机制，生物学和基因组学。我的最终目标是成为一名研究儿科癌症的独立医生科学家。我很高兴这次培训经验将有效地为我在转化癌症研究中的职业生涯做好准备。